Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren R Tyson

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Scientific Reports|July 20, 2017
A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast CancerMatthew T McKenna, Jared A Weis, Stephanie L Barnes, et al.
Biophysical Journal|March 29, 2018
A Nonquiescent "Idling" Population State in Drug-Treated, BRAF-Mutated MelanomaB Bishal Paudel, Leonard A Harris, Keisha N Hardeman, et al.
Engineering with Computers|December 2, 2024
A global sensitivity analysis of a mechanistic model of neoadjuvant chemotherapy for triple negative breast cancer constrained by in vitro and in vivo imaging dataGuillermo Lorenzo, Angela M Jarrett, Christian T Meyer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 8, 2016
Altered TGF-α/β signaling drives cooperation between breast cancer cell populationsOmar E Franco, Darren R Tyson, Katherine C Konvinse, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Heterogeneous, population-level drug-tolerant persisters exhibit ion-channel remodeling and ferroptosis susceptibilityCorey E Hayford, Blake Baleami, Philip E Stauffer, et al.
Plos Computational Biology|November 1, 2019
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizersDavid J Wooten, Sarah M Groves, Darren R Tyson, et al.
Nature Methods|May 3, 2016
An unbiased metric of antiproliferative drug effect in vitroLeonard A Harris, Peter L Frick, Shawn P Garbett, et al.
Scientific Reports|February 17, 2017
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF InhibitionKeisha N Hardeman, Chengwei Peng, Bishal B Paudel, et al.
The Journal of Urology|August 18, 2009
Periprostatic adipose tissue as a modulator of prostate cancer aggressivenessDavid S Finley, Valerie S Calvert, Junichi Inokuchi, et al.
Molecular Cancer|July 27, 2012
Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt modelToshiyuki Tsunoda, Takeharu Ota, Takahiro Fujimoto, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Scientific Reports|July 20, 2017
A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast CancerMatthew T McKenna, Jared A Weis, Stephanie L Barnes, et al.
Biophysical Journal|March 29, 2018
A Nonquiescent "Idling" Population State in Drug-Treated, BRAF-Mutated MelanomaB Bishal Paudel, Leonard A Harris, Keisha N Hardeman, et al.
Engineering with Computers|December 2, 2024
A global sensitivity analysis of a mechanistic model of neoadjuvant chemotherapy for triple negative breast cancer constrained by in vitro and in vivo imaging dataGuillermo Lorenzo, Angela M Jarrett, Christian T Meyer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 8, 2016
Altered TGF-α/β signaling drives cooperation between breast cancer cell populationsOmar E Franco, Darren R Tyson, Katherine C Konvinse, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Heterogeneous, population-level drug-tolerant persisters exhibit ion-channel remodeling and ferroptosis susceptibilityCorey E Hayford, Blake Baleami, Philip E Stauffer, et al.
Plos Computational Biology|November 1, 2019
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizersDavid J Wooten, Sarah M Groves, Darren R Tyson, et al.
Nature Methods|May 3, 2016
An unbiased metric of antiproliferative drug effect in vitroLeonard A Harris, Peter L Frick, Shawn P Garbett, et al.
Scientific Reports|February 17, 2017
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF InhibitionKeisha N Hardeman, Chengwei Peng, Bishal B Paudel, et al.
The Journal of Urology|August 18, 2009
Periprostatic adipose tissue as a modulator of prostate cancer aggressivenessDavid S Finley, Valerie S Calvert, Junichi Inokuchi, et al.
Molecular Cancer|July 27, 2012
Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt modelToshiyuki Tsunoda, Takeharu Ota, Takahiro Fujimoto, et al.
Pageof 6